BRD2 and obesity due to melanocortin 4 receptor deficiency: Although FSH is often monitored in a clinical setting to help determine menopausal status, it alone is insufficient to diagnose menopause due to extreme variability during the MT, as well as susceptibility to factors such as hormonal contraceptives, hormone replacement therapy, and obesity [5, 18].